← ANALYST RATINGS · TIPRANKS
Pennant Group (PNTG): analyst forecast and price target
Analyst consensus
Strong Buy4 Buy0 Hold0 Sell
Ratings of 4 analysts in the last 3 months · top analysts only12-month forecast
Based on 4 price targets given in the last 3 months, the average target is $46.00, the highest $48.00, the lowest $44.00. The average is +9.9% from the last price of $41.87.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI DeepSeek Medical - Care FacilitiesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $45.00 → $44.00−2.2% | Hold | +5.1% | Reiterated | 17.10.26on TipRanks 04:05 | — | |
| AI OpenAI Medical - Care FacilitiesOpenAI 5.2 | TipRanks - OpenAI | $45.00 → $44.00−2.2% | Hold | +5.1% | Reiterated | 17.10.26on TipRanks 04:05 | — | |
| AI Anthropic Medical - Care FacilitiesAnthropic Opus-4.6 | TipRanks - Anthropic | $45.00 → $44.00−2.2% | Hold | +5.1% | Reiterated | 17.10.26on TipRanks 04:05 | — | |
| AI Google Medical - Care FacilitiesGemini 3.1Pro | TipRanks - Google | $46.00 → $45.00−2.2% | Hold | +7.5% | Downgrade | 17.10.26on TipRanks 04:05 | — | |
| AI PerPlexity Medical - Care FacilitiesPerPlexity SonarPro | TipRanks - PerPlexity | $46.00 → $45.00−2.2% | Hold | +7.5% | Downgrade | 17.10.26on TipRanks 04:05 | — | |
| David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% | Truist Financial | $48.00 | Buy | +14.6% | Reiterated | 23.09.26on TipRanks 07:30 | +1.3%next day 0.0% · 5 days −1.0% | ↗ |
| AI xAi Medical - Care FacilitiesxAI Grok-4 | TipRanks - xAI | $41.00 → $45.00+9.8% | Hold | +7.5% | Downgrade | 17.09.26on TipRanks 05:05 | — | |
| Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% | RBC Capital | $42.00 → $44.00+4.8% | Buy | +5.1% | Reiterated | 19.08.26on TipRanks Aug 20 07:15 | −0.9%next day +0.5% · 5 days −1.8% | ↗ |
| Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% | Wells Fargo | $45.00 → $46.00+2.2% | Buy | +9.9% | Assigned | 10.08.26on TipRanks Aug 11 05:08 | +1.7%next day −3.4% · 5 days −1.1% | ↗ |
| Jared Haase★★★★★★★★★★#1700 · hits 89% · avg +24.8% | William Blair | — | Buy | — | Reiterated | 05.08.26on TipRanks 17:55 | +0.8%next day −0.8% · 5 days −2.3% | ↗ |
| Michael Wiederhorn★★★★★★★★★★#535 · hits 59% · avg +11.3% | Oppenheimer | $37.00 → $40.00+8.1% | Buy | −4.5% | Reiterated | 08.05.26on TipRanks 08:45 | −0.3%next day −5.2% · 5 days −1.2% | ↗ |
| Unknown Analyst | Stephens | $30.35 → $37.00+21.9% | Buy | −11.6% | Reiterated | 02.04.26on TipRanks Apr 3 10:15 | −2.4%next day +0.4% · 5 days −0.2% | ↗ |
| Brian Tanquilut★★★★★★★★★★#1681 · hits 52% · avg +6.6% | Jefferies | $30.00 → $40.00+33.3% | Buy | −4.5% | Reiterated | 16.12.25on TipRanks 08:45 | +0.3%next day 0.0% · 5 days −2.9% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Pennant Group
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $46.00 at a price of $39.00 (+17.9%); now: $46.00 at $41.87 (+9.9%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 9 | 7 | 9 | 8 | 8 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 09.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.36 (from $0.33 to $0.37). Last quarter: $0.36.
Sales
Next quarter’s sales estimate — $299M (from $297M to $303M). Last quarter: $298M.
Best top-analyst consensus in the sector · Healthcare
About Pennant Group
- CEO: Brent J. Guerisoli
- Employees: 9,700
- 1675 East Riverside Drive, Eagle, ID, 83616, US
- www.pennantgroup.com
The Pennant Group, Inc. is a U.S.-based healthcare provider, delivering a diverse range of services through two core divisions: Home Health and Hospice Services, and Senior Living Services. The company's Home Health segment offers in-home clinical support, encompassing nursing, speech, occupational, and physical therapy, as well as medical social work and home health aide assistance. Its Hospice services focus on providing comprehensive clinical care, education, and counseling to meet the physical, spiritual, and psychosocial needs of terminally ill patients and their families. In its Senior Living division, Pennant provides residential accommodations, organized activities, meals, housekeeping, and aid with daily living tasks for seniors who are either independent or require some support. As of December 31, 2021, the company's extensive operational footprint included 88 home health and hospice agencies and 54 senior living communities, collectively featuring 4,127 senior living units. These facilities are located across Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was established in 2019 and maintains its corporate headquarters in Eagle, Idaho.
Data from the stock’s TipRanks forecast page, read 199 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗